1.Cazzato RL, Garnon J, Ramamurthy N, et al.Percutaneous image-guided cryoablation: current applications and results in the oncologic field.Med Oncol. 2016;33:140. doi:10.1007/s12032-016-0848-3 [PubMed] [CrossRef][Google Scholar]
2.Pusceddu C, Melis L, Ballicu N, et al.Percutaneous microwave ablation under CT guidance for hepatocellular carcinoma: a single institutional experience.J Gastrointest Cancer. 2018;49(3):295–301. doi:10.1007/s12029-017-9951-8 [PubMed] [CrossRef][Google Scholar]
3.Mahnken AH, König AM, Figiel JH.Current Technique and Application of Percutaneous Cryotherapy.Rofo. 2018;190:836–846. doi:10.1055/a-0598-5134 [PubMed] [CrossRef][Google Scholar]
4.Pusceddu C, Melis L, Sotgia B, Guerzoni D, Porcu A, Fancellu A.Usefulness of percutaneous microwave ablation for large non-small cell lung cancer: apreliminary report.Oncol Lett. 2019;18:659–666. doi:10.3892/ol.2019.10375[PMC free article][PubMed] [CrossRef][Google Scholar]
5.Zhao Z, Wu F.Minimally-invasive thermal ablation of early-stage breast cancer: a systematic review.Eur J Surg Oncol. 2010;36:1149–1155. doi:10.1016/j.ejso.2010.09.012 [PubMed] [CrossRef][Google Scholar]
6.Machida Y, Shimauchi A, Igarashi T, f*ckuma E.MRI findings after cryoablation of primary breast cancer without surgical resection.Acad Radiol. 2019;26:744–751. doi:10.1016/j.acra.2018.07.012 [PubMed] [CrossRef][Google Scholar]
7.Mauri G, Sconfienza LM, Pescatori LC, et al.Technical success, technique efficacy and complications of minimally-invasive imaging-guided percutaneous ablation procedures of breast cancer: A systematic review and meta-analysis.Eur Radiol. 2017;27(8):3199–3210. doi:10.1007/s00330-016-4668-9 [PubMed] [CrossRef][Google Scholar]
8.Lanza E, Palussiere J, Buy X, et al.Percutaneous image-guided cryoablation of breast cancer: a systematic review.J Vasc Interv Radiol. 2015;26:1652–1657. doi:10.1016/j.jvir.2015.07.020 [PubMed] [CrossRef][Google Scholar]
9.Nguyen T, Hattery E, Khatri VP.Radiofrequency ablation and breast cancer: a review.Gland Surg. 2014;3:128–135. doi:10.3978/j.issn.2227-684X.2014.03.05[PMC free article][PubMed] [CrossRef][Google Scholar]
10.Rui J, Tatsutani KN, Dahiya R, Rubinsky B.Effect of thermal variables on human breast cancer in cryosurgery.Breast Cancer Res Treat. 1999;53:185–192. doi:10.1023/A:1006182618414 [PubMed] [CrossRef][Google Scholar]
11.Pusceddu C, Melis L, Sotgia B, Fancellu A, Meloni GB.Computed tomography-guided cryoablation of local recurrence after primary resection of pancreatic adenocarcinoma.Clin Pract. 2015;5:741. doi:10.4081/cp.2015.741[PMC free article][PubMed] [CrossRef][Google Scholar]
12.Pusceddu C, Sotgia B, Amucano G, et al.Breast cryoablation in patients with bone metastatic breast cancer.J Vasc Interv Radiol. 2014;25:1225–1232. doi:10.1016/j.jvir.2014.05.001 [PubMed] [CrossRef][Google Scholar]
13.Chu KF, Dupuy DE.Thermal ablation of tumors: biological mechanisms and advances in therapy.Nat Rev Cancer. 2014;14:199–208. doi:10.1038/nrc3672 [PubMed] [CrossRef][Google Scholar]
14.Tafra L, Smith SJ, Woodward JE, Fernandez KL, Sawyer KT, Grenko RT.Pilot trial of cryoprobe-assisted breast-conserving surgery for small ultrasound-visible cancers.Ann Surg Oncol. 2003;10:1018–1024. doi:10.1245/aso.2003.04.002 [PubMed] [CrossRef][Google Scholar]
15.Tarkowski R, Rzaca M.Cryosurgery in the treatment of women with breast cancer—a review.Gland Surg. 2014;3:88–89. doi:10.3978/j.issn.2227-684X.2014.03.04[PMC free article][PubMed] [CrossRef][Google Scholar]
16.Morin J, Traore A, Dionne G, et al.Magnetic resonance guided percutaneous cryosurgery of breast carcinoma: technique and early clinical results.Can J Surg. 2004;47:347–351.[PMC free article][PubMed][Google Scholar]
17.Pusztaszeri M, Vlastos G, Kinkel K, et al.Histopathological study of breast cancer and normal breast tissue after magnetic resonance-guided cryotherapy ablation.Cryobiology. 2007;55:44–51. doi:10.1016/j.cryobiol.2007.05.002 [PubMed] [CrossRef][Google Scholar]
18.Littrup PJ, Jallad B, Chandiwala-Mody P, D’Agostini M, Adam BA, Bouwman D.Cryotherapy for breast cancer: a feasibility study without excision.J Vasc Interv Radiol. 2009;20:1329–1341. doi:10.1016/j.jvir.2009.06.029[PMC free article][PubMed] [CrossRef][Google Scholar]
19.Chandra D, Jahangir A, Cornelis F, et al.Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.Oncoimmunology. 2015;5:e1049802. doi:10.1080/2162402X.2015.1049802[PMC free article][PubMed] [CrossRef][Google Scholar]
20.Pusceddu C, Melis L, Ballicu N, et al.Cryoablation of primary breast cancer in patients with metastatic disease: considerations arising from a single-centre data analysis.Biomed Res Int. 2017;2017:3839012. doi:10.1155/2017/3839012[PMC free article][PubMed] [CrossRef][Google Scholar]
21.Fleming MM, Holbrook AI, Newell MS.Update on image-guided percutaneous ablation of breast cancer.AJR. 2017;208:267–274. doi:10.2214/AJR.16.16984 [PubMed] [CrossRef][Google Scholar]
22.Fancellu A, Sanna V, Sedda ML, et al.Benefits of organized mammographic screening programs in women aged 50 to 69 years: a surgical perspective.Clin Breast Cancer. 2019. doi:10.1016/j.clbc.2019.04.013 [PubMed] [CrossRef][Google Scholar]
23.Fancellu A, Sanna V, Cottu P, et al.Mastectomy patterns, but not rates, are changing in the treatment of early breast cancer. Experience of a single European institution on 2315 consecutive patients.Breast. 2018;39:1–7. doi:10.1016/j.breast.2018.02.003 [PubMed] [CrossRef][Google Scholar]
24.Fancellu A, Cottu P, Feo CF, et al.Sentinel node biopsy in early breast cancer: lessons learned from more than 1000 cases at a single institution.Tumori. 2012;98:413–420. doi:10.1700/1146.12633 [PubMed] [CrossRef][Google Scholar]
25.Gambardella C, Clarizia G, Patrone R, et al.Advanced hemostasis in axillary lymph node dissection for locally advanced breast cancer: new technology devices compared in the prevention of seroma formation.BMC Surg. 2019;18(Suppl 1):125. doi:10.1186/s12893-018-0454-8 [PubMed] [CrossRef][Google Scholar]
26.Niu L, Wu B, Xu K.Cryosurgery for breast fibroadenomas.Gland Surg. 2012;1:128–131. doi:10.3978/j.issn.2227-684X.2012.08.02[PMC free article][PubMed] [CrossRef][Google Scholar]
27.Kaufman CS, Littrup PJ, Freeman-Gibb LA, et al.Office-based cryoablation of breast fibroadenomas with long-term follow-up.Breast J. 2005;11:344–350. doi:10.1111/j.1075-122X.2005.21700.x [PubMed] [CrossRef][Google Scholar]
28.Littrup PJ, Freeman-Gibb L, Andea A, et al.Cryotherapy for breast fibroadenomas.Radiology. 2005;234:63–72. doi:10.1148/radiol.2341030931 [PubMed] [CrossRef][Google Scholar]
29.Paepke S, Metz S, Brea Salvago A, Ohlinger R.Benign breast tumours - diagnosis and management.Breast Care (Basel). 2018;13:403–412. doi:10.1159/000495919[PMC free article][PubMed] [CrossRef][Google Scholar]
30.Sabel MS, Kaufman CS, Whitworth P, et al.Cryoablation of early-stage breast cancer: work-in-progress report of a multi-institutional trial.Ann Surg Oncol. 2004;11:542–549. doi:10.1245/ASO.2004.08.003 [PubMed] [CrossRef][Google Scholar]
31.Poplack SP, Levine GM, Henry L, et al.A pilot study of ultrasound-guided cryoablation of invasive ductal carcinomas up to 15 mm with MRI follow-up and subsequent surgical resection.AJR Am J Roentgenol. 2015;204:1100–1108. doi:10.2214/AJR.13.12325[PMC free article][PubMed] [CrossRef][Google Scholar]
32.Simmons RM, Ballman KV, Cox C, et al.; ACOSOG investigators.A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: results from ACOSOG (Alliance) Z1072.Ann Surg Oncol. 2016;23:2438–2445. doi:10.1245/s10434-016-5275-3[PMC free article][PubMed] [CrossRef][Google Scholar]
33.Gajda MR, Mireskandari M, Baltzer PA, et al.Breast pathology after cryotherapy. Histological regression of breast cancer after cryotherapy.Pol J Pathol. 2014;65:20–28. doi:10.5114/pjp.2014.42665 [PubMed] [CrossRef][Google Scholar]
34.Manenti G, Scarano AL, Pistolese CA, et al.Subclinical breast cancer: minimally invasive approaches. Our experience with percutaneous radiofrequency ablation vs. cryotherapy.Breast Care (Basel). 2013;8:356–360. doi:10.1159/000355707[PMC free article][PubMed] [CrossRef][Google Scholar]
35.Cazzato RL, de Lara CT, Buy X, et al.Single-centre experience with percutaneous cryoablation of breast cancer in 23 consecutive non-surgical patients.Cardiovasc Intervent Radiol. 2015;38:1237–1243. doi:10.1007/s00270-015-1181-5 [PubMed] [CrossRef][Google Scholar]
36.Cryoablation of Small Breast Tumors in Early Stage Breast Cancer (FROST). Available from: https://clinicaltrials.gov/ct2/show/NCT01992250. Accessed July 20, 2019.
37.Cryoablation of Low Risk Small Breast Cancer- Ice3 Trial. Available from: https://clinicaltrials.gov/ct2/show/NCT02200705. Accessed July 20, 2019.
38.Pfleiderer SO, Marx C, Camara O, Gajda M, Kaiser WA.Ultrasound-guided, percutaneous cryotherapy of small (< or = 15 mm) breast cancers.Invest Radiol. 2005;40:472–477. doi:10.1097/01.rli.0000166935.56971.ff [PubMed] [CrossRef][Google Scholar]
39.Beji H, Pilleul F, Picard R, et al.Percutaneous cryoablation of breast tumors in patients with stable metastatic breast cancer: safety, feasibility and efficacy.Br J Radiol. 2018;91(1083):20170500. doi:10.1259/bjr.20170500[PMC free article][PubMed] [CrossRef][Google Scholar]
40.Fancellu A, Soro D, Castiglia P, et al.Usefulness of magnetic resonance in patients with invasive cancer eligible for breast conservation: a comparative study.Clin Breast Cancer. 2014;14:114–121. doi:10.1016/j.clbc.2013.10.002 [PubMed] [CrossRef][Google Scholar]
41.Fancellu A, Turner RM, Dixon JM, Pinna A, Cottu P, Houssami N.Meta-analysis of the effect of preoperative breast MRI on the surgical management of ducal carcinoma in situ.Br J Surg. 2015;102:883–893. doi:10.1002/bjs.9797 [PubMed] [CrossRef][Google Scholar]
42.Pediconi F, Marzocca F, Cavallo Marincola B, Napoli A.MRI-guided treatment in the breast.J Magn Reson Imaging. 2018;48:1479–1488. doi:10.1002/jmri.26282 [PubMed] [CrossRef][Google Scholar]
43.Sabel MS, Nehs MA, Su GK, et al.Immunologic response to cryoablation of breast cancer.Breast Cancer Res Treat. 2005;90:97–104. doi:10.1007/s10549-004-3289-1 [PubMed] [CrossRef][Google Scholar]
44.Abdo J, Cornell DL, Mittal SK, Agrawal DK.Immunotherapy plus cryotherapy: potential augmented abscopal effect for advanced cancers.Front Oncol. 2018;8:85. doi:10.3389/fonc.2018.00085[PMC free article][PubMed] [CrossRef][Google Scholar]
45.Keisari Y.Tumor abolition and antitumor immunostimulation by physico-chemical tumor ablation.Front Biosci. 2017;22:310–347. doi:10.2741/4487 [PubMed] [CrossRef][Google Scholar]
46.Sidana A.Cancer immunotherapy using tumor cryoablation.Immunotherapy. 2014;6:85–93. doi:10.2217/imt.13.151 [PubMed] [CrossRef][Google Scholar]
47.McArthur HL, Diab A, Page DB, et al.A pilot study of preoperative single-dose ipilimumab and/or cryoablation in women with early stage breast cancer with comprehensive immune profiling.Clin Cancer Res. 2016;22:5729–5737. doi:10.1158/1078-0432.CCR-16-0190[PMC free article][PubMed] [CrossRef][Google Scholar]
48.Liang S, Niu L, Xu K, et al.Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancer.Mol Immunol. 2017;92:45–53. doi:10.1016/j.molimm.2017.10.003 [PubMed] [CrossRef][Google Scholar]
49.Ye P, Yin H, Gu X, et al.Improved synergetic therapy efficiency of cryoablation and nanoparticles for MCF-7 breast cancer.Nanomedicine (Lond). 2018;13:1889–1903. doi:10.2217/nnm-2018-0168 [PubMed] [CrossRef][Google Scholar]
